Gujarat Terce Laboratories
49.05
-1.47(-2.91%)
Market Cap₹13.40 Cr
PE Ratio143.88
IndustryHealthcare
Company Performance:
1D-2.91%
1M-9.05%
6M-37.19%
1Y+5.17%
5Y+507.05%
View Company Insightsright
Latest news about Gujarat Terce Laboratories
Gujarat Terce Laboratories Reports Net Loss Despite Revenue Growth, Settles Tax Disputes 4 days ago
Gujarat Terce Laboratories Limited reported a 3.93% increase in total revenue to ₹50.20 crore, with sales rising 4.58% to ₹50.20 crore. EBITDA surged 143.12% to ₹3.89 crore, improving the EBITDA margin from 3.31% to 7.75%. However, the company faced a net loss of ₹0.98 crore due to a one-time tax settlement provision of ₹3.42 crore. The company reduced its debt-to-equity ratio from 0.54 to 0.15 and achieved zero borrowing in Q4. Operational improvements included better inventory and receivables management.